Advanced Medical Optics Wins Omega NorthFace ScoreBoard Award for Excellence in Customer Satisfaction.
The NorthFace ScoreBoard Award is presented annually by the Omega Management Group Corp. to companies who achieved excellence in customer satisfaction during the prior calendar year. A total of 27 companies qualified to receive the award for 2007.
Omega's methodology measures customer satisfaction and loyalty levels for all clients on a five point scale a minimum of twice during the calendar year in such categories as technical support, field service, customer service and account management. NorthFace ScoreBoard Award recipients are companies who, based on survey responses from their own customers, achieved a 4.0 or above out of a possible 5.0.
"Receiving this award for the seventh time clearly demonstrates AMO's commitment to achieving customer loyalty through exemplary service," said AMO Senior Vice President, Global Customer Services Angelo Rago. "It further demonstrates AMO's strength of process integration to take the award-winning VISX customer culture and make it standard for service across the organization. Our goal is to continually look at ways to innovate and improve upon the customer experience. The NorthFace ScoreBoard Award validates what we've been working toward, which is to create value by constantly innovating and evolving to meet the needs of our customers. We are honored to be recognized by Omega for this achievement."
AMO will formally receive the award during ceremonies on May 15 at Omega's SCORE Conference 2008 at the Boston World Trade Center. For more information on Omega and SCORE Conference 2008, visit www.omegascoreboard.com or call (866) 610-6700.
About Advanced Medical Optics (AMO)
AMO is focused on providing the full range of advanced refractive technologies and support to help eye care professionals deliver optimal vision and lifestyle experiences to patients of all ages. Products in the cataract/implant line include intraocular lenses (IOLs), phacoemulsification systems, viscoelastics, and related products used in ocular surgery. AMO owns or has the rights to such product brands as ReZoom([R]), Tecnis([R]), Clariflex([R]), Sensar([R]), and Verisyse([R]) IOLs, Sovereign([R]), Sovereign([R]) Compact and WhiteStar Signature([TM]) phacoemulsification systems with WhiteStar([R]) technology, Healon([R]) viscoelastics, and the Baerveldt([R]) glaucoma shunt. Products in the laser vision correction line include wavefront diagnostic devices, femtosecond lasers and associated patient interface devices, and excimer laser vision correction systems and treatment cards. AMO brands in the laser vision correction business include Star S4 IR([R]), WaveScan Wavefront([R]), Advanced CustomVue([R]), IntraLase([R]), IntraLasik([R]) and iLasik [TM]. Products in the eye care line include dry eye drops and contact lens disinfecting solutions, enzymatic cleaners and lens rewetting drops. Among the eye care product brands the company possesses are COMPLETE([R]), COMPLETE([R]) Blink-N-Clean([R]), Consept([R])F, Consept([R]) 1 Step, Oxysept([R]), UltraCare([R]), Ultrazyme([R]), Total Care([TM]) and blink[TM] branded products. AMO is based in Santa Ana, California, and employs approximately 4,000 worldwide. The company has operations in 24 countries and markets products in approximately 60 countries. For more information, visit the company's Website at www.amo-inc.com.
This press release contains forward-looking statements about AMO, including statements by Mr. Rago relating to AMO's customer service goals. All forward-looking statements in this press release represent AMO's judgment only as of the date of this press release. Actual results may differ from current expectations based on a number of factors. Therefore, the reader is cautioned not to rely on these forward-looking statements. AMO disclaims any intent or obligation to update these forward-looking statements. Additional information concerning these and other risk factors may be found in previous press releases issued by AMO and AMO's public periodic filings with the Securities and Exchange Commission, including the discussion under the heading "Risk Factors" in AMO's 2007 Form 10-K filed in March 2008. Copies of press releases and additional information about AMO are available at www.amo-inc.com.
All trademarks, service marks and company names are the property of their respective owners.
|Printer friendly Cite/link Email Feedback|
|Date:||Apr 15, 2008|
|Previous Article:||North American Scientific Scheduled for Nasdaq Listing Hearing on May 22, 2008.|
|Next Article:||NorthgateArinso to Deliver Outsourced Talent Management Based On SAP(R) ERP Human Capital Management.|